[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-357228-105":59,"doc-detail-357228-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","trf-3017b-promotes-prostate-cancer-progression-research-findings-on-cell-proliferation-ctl-resistance-and-m2-macrophage-polarization-cytokine-mediated-stat3-signaling","tRF-3017b promotes prostate cancer progression - research findings on cell proliferation, CTL resistance, and M2 macrophage polarization - cytokine-mediated STAT3 signaling","","tRF-3017b expression is markedly increased in paired prostate cancer (PCa) tissues versus adjacent normal samples, and functional inhibition suppresses PCa cell proliferation while lowering immunosuppressive cytokines including IL-10, TGF-β1, CSF1, and CCL2. In co-culture, tRF-3017b knockdown enhances CTL-mediated tumor cell killing and disrupts M2 macrophage polarization, reducing ARG1, IL-10, CD206, and p-STAT3 activation. These results suggest tRF-3017b drives PCa progression via cytokine-mediated STAT3 signaling and regulates tumor–immune crosstalk, indicating therapeutic potential for reprogramming the immunosuppressive microenvironment.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/trf-3017b-promotes-prostate-cancer-progression-research-findings-on-cell-proliferation-ctl-resistance-and-m2-macrophage-polarization-cytokine-mediated-stat3-signaling/357228/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/trf-3017b-promotes-prostate-cancer-progression-research-findings-on-cell-proliferation-ctl-resistance-and-m2-macrophage-polarization-cytokine-mediated-stat3-signaling/357228.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What role does tRF-3017b play in prostate cancer?","Question",{"text":112,"@type":113},"tRF-3017b is upregulated in prostate cancer tissues and promotes tumor progression by enhancing cell proliferation and immune evasion through modulation of CTLs and M2 macrophage polarization.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the expression of tRF-3017b assessed?",{"text":117,"@type":113},"tRF-3017b expression was measured in 40 paired PCa and adjacent normal tissues using quantitative RT-PCR.",{"name":119,"@type":110,"acceptedAnswer":120},"What happens when tRF-3017b is silenced in tumor cells?",{"text":121,"@type":113},"Silencing tRF-3017b inhibits LNCaP cell proliferation and reduces secretion of immunosuppressive cytokines such as IL-10, TGF-β1, CSF1, and CCL2.",{"name":123,"@type":110,"acceptedAnswer":124},"Why is STAT3 signaling important in this study?",{"text":125,"@type":113},"The study links tRF-3017b to cytokine-mediated STAT3 activation; knockdown reduces p-STAT3 and impairs M2 polarization and CTL resistance.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},357228,1790796791,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \ntRF-3017b promotes prostate cancer progression by enhancing cell proliferation, CTL resistance, and M2 macrophage polarization  \nXiaowu Liu, Zhimin Jiao, Yunfeng Shi, Chengyue Wang, Xiaoliang Yuan, Chengshuai Wu & Haoran Wu􀀍  \nThis research sought to assess the expression pattern and biological function oftRF-3017b in prostate cancer, and to elucidate whether tRF-3017b promotes tumor progression by modulating tumor cell proliferation, cytotoxic T lymphocyte (CTL) resistance, and M2 macrophage polarization through cytokine-mediated STAT3 signaling. The expression oftRF-3017b was examined in 40 paired PCa and adjacent normal tissues using quantitative RT-PCR. LNCaP cells were transfected with tRF-3017b inhibitors to evaluate their proliferative capacity, cytokine secretion, and immune interactions. Coculture systems were established between LNCaP cells and CTLs orTHP-1-derived macrophages. Cell proliferation (CCK-8), cytokine levels (ELISA), macrophage markers (qRT-PCR, immunofluorescence), migration (Transwell assay), and STAT3 activation (Western blot) were systematically analyzed. tRF- 3017b levels were markedly elevated in prostate cancer tissues relative to paired normal counterparts (P \u003C 0.001). Silencing tRF-3017b significantly inhibited LNCaP cell proliferation and reduced the secretion of immunosuppressive cytokines, such as IL-10, TGF-β1, CSF1, and CCL2 . In co-culture assays, tRF-3017b knockdown enhanced CTL-mediated cytotoxicity against tumor cells and impaired M2 macrophage polarization, as shown by the diminished expression of ARG1, IL-10, and CD206 and reduced p-STAT3 activation. Our findings suggest that tRF-3017b may contribute to prostate cancer progression by regulating tumor proliferation and immune modulation in vitro, particularly through the cytokine-mediated STAT3 signaling axis. These findings identify tRF-3017b as a novel regulator of tumor–immune crosstalk and a promising therapeutic target for reprogramming the immunosuppressive microenvironment in prostate cancer.  \nKeywords Prostate cancer, tRNA-derived fragment tRF-3017b, Tumor microenvironment, M2 macrophage polarization, STAT3 signaling pathway  \nProstate cancer (PCa) ranks among the most prevalent malignancies affecting men and continues to be a major contributor to cancer-associated deaths globally. According to the GLOBOCAN 2022 data report, PCa accounted for 1.47 million new cases and nearly 400,000 deaths globally, representing a steady increase in both incidence and prevalence over the past three decades1. The age-standardized incidence rate (ASIR) of PCa has risen from 13.7 to 15.4 per 100,000 men since 1990, largely driven by population aging, lifestyle changes, and widespread prostate-specific antigen (PSA) screening2. In contrast, mortality rates have plateaued in many high-income countries but continue to rise in developing regions, especially Asia, reflecting disparities in early detection and therapeutic accessibility3.Despite remarkable advances in androgen deprivation therapy (ADT), chemotherapy, and immune checkpoint blockade, a significant subset of patients develop castration-resistant prostate cancer (CRPC) or metastatic disease, for which effective treatment options remain limited4. These clinical challenges underscore the need to explore novel molecular mechanisms that underlie PCa progression and immune evasion, beyond androgen receptor (AR) signaling alone.  \nThe progression of PCa is increasingly recognized as being governed not only by intrinsic oncogenic alterations but also by a highly dynamic tumor microenvironment (TME). The TME ofPCa is typically characterized by an immunosuppressive phenotype, featuring reduced cytotoxic T lymphocyte (CTL) activity and accumulation of  \nDepartment of Urology, Wujin Hospital Affiliated with Jiangsu University, The Wujin Clinical College of Xuzhou Medical University, Changzhou 213000, Jiangsu, China. 􀀍 ema","cbCaifbPey4PrfqQ","https://ap.wps.com/l/cbCaifbPey4PrfqQ","pdf",3030455,11,"English","# Background\n## Clinical challenge in prostate cancer progression and immune evasion\n## Tumor microenvironment and M2 macrophage polarization\n## Non-coding RNAs and tRNA-derived fragments (tRFs)\n# Findings and experimental approach\n## Expression analysis in paired human tissues\n## Effects of tRF-3017b inhibition on proliferation and cytokines\n## Co-culture assays with CTLs and macrophages\n## STAT3 activation and mechanistic link\n# Conclusion and therapeutic implications","[{\"question\":\"What role does tRF-3017b play in prostate cancer?\",\"answer\":\"tRF-3017b is upregulated in prostate cancer tissues and promotes tumor progression by enhancing cell proliferation and immune evasion through modulation of CTLs and M2 macrophage polarization.\"},{\"question\":\"How was the expression of tRF-3017b assessed?\",\"answer\":\"tRF-3017b expression was measured in 40 paired PCa and adjacent normal tissues using quantitative RT-PCR.\"},{\"question\":\"What happens when tRF-3017b is silenced in tumor cells?\",\"answer\":\"Silencing tRF-3017b inhibits LNCaP cell proliferation and reduces secretion of immunosuppressive cytokines such as IL-10, TGF-β1, CSF1, and CCL2.\"},{\"question\":\"Why is STAT3 signaling important in this study?\",\"answer\":\"The study links tRF-3017b to cytokine-mediated STAT3 activation; knockdown reduces p-STAT3 and impairs M2 polarization and CTL resistance.\"}]","tRF-3017b promotes prostate cancer progression - research findings on cell proliferation, CTL resistance, and M2 macrophage polarization - cytokine-mediated STAT3 signaling | PDF",1790129407,28,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb985e72863664e0aa567912f1dc6448.webp",983,1291,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e8cbc5c2e5b7286e8fbf066201d3b36.webp",982,1290,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c06e202b3f7d6ecfd6fab786f0149dd4.webp",981,1289,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53098d7a34c0a0e14b5eb1b24985d015.webp",980,1287]